ANDA 87567, held by Baxter Hlthcare. Hydrocortisone Sodium Succinate.
As of Nov 16, 2026, ANDA 87567 (Hydrocortisone Sodium Succinate), held by Baxter Hlthcare, was first approved by FDA on May 28, 1981, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 28, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrocortisone Sodium SuccinateEQ 250MG BASE/VIAL ยท injectable;injection | Hydrocortisone Sodium Succinate | Discontinued |
| May 5, 1988 | Supplement 10Labeling | Approved | None posted |
| Jan 13, 1987 | Supplement 9Manufacturing | Approved | None posted |
| Nov 3, 1986 | Supplement 5Manufacturing | Approved | None posted |
| Dec 26, 1985 | Supplement 8Manufacturing | Approved | None posted |
| Feb 1, 1983 | Supplement 3Manufacturing | Approved | None posted |
| May 28, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters